Globus Medical (GMED) Net Cash Flow Growth (3y) (2014 - 2026)
Globus Medical (GMED) Net Cash Flow Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -9.45% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 60.16% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | -85.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 43.26% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | -26.30% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 21.48% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -127.77% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 269.22% |
| 10 | Globus Medical | 11.64 Bn | 11.04 Bn | 548.17 Mn | -37.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -37.67% |
| Mar 31, 2026 | -17.41% |
| Dec 31, 2025 | 106.47% |
| Sep 30, 2025 | 117.77% |
| Jun 30, 2025 | -46.22% |
| Mar 31, 2025 | -121.50% |
| Dec 31, 2024 | 43.98% |
| Sep 30, 2024 | 30.81% |
| Jun 30, 2024 | -14.44% |
| Mar 31, 2024 | -26.75% |
| Dec 31, 2023 | 162.44% |
| Sep 30, 2023 | -32.80% |
| Jun 30, 2023 | 332.19% |
| Mar 31, 2023 | 62.88% |
| Dec 31, 2022 | -16.61% |
| Sep 30, 2022 | -32.93% |
| Jun 30, 2022 | -85.13% |
| Mar 31, 2022 | 79.53% |
| Sep 30, 2021 | 66.98% |
| Jun 30, 2021 | 317.97% |